Retatrutide × Peptide Partners - Lab Test, October 2025
Test results
About this test
This independent LC-MS lab test confirms Retatrutide 20mg from Peptide Partners at 98.979% purity. The analysis was conducted by Trust Pointe Analytics on October 14, 2025.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. The tested quantity of 23.150mg demonstrates consistent formulation across three vials with the labeled 20mg. A purity level of 98.979% indicates minimal contamination and high-grade synthesis.
Note: The lab reports an early eluting peak before void volume time, consistent with elution time and UV spectrum of Glycine on this test method. Adjusted purity omitting Glycine is 99.924%, 99.762%, and 99.918%. The full certificate of analysis is available for download on this page (Key: 7B3ACKHD3E94).Haiku 4.5
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.